{"data":{"id":"us-in/ic-27-13-42-1","jurisdiction":"us-in","citation":"IC 27-13-42-1","heading":"Allowing a health maintenance organization to report the number of children enrollees who are prescribed stimulant medication for the treatment of certain disorders","body":"Sec. 1. A health maintenance organization that enters into an individual contract or a group contract that provides a prescription drug benefit may report to the drug utilization review board established by IC 12-15-35-19, not later than October 1 of each calendar year, the number of enrollees who are:\n(1) less than eighteen (18) years of age; and\n(2) prescribed a stimulant medication approved by the federal Food and Drug Administration for the treatment of attention deficit disorder or attention deficit hyperactivity disorder.","path":["TITLE 27. INSURANCE","ARTICLE 13. HEALTH MAINTENANCE ORGANIZATIONS","Chapter 42. Specific Reporting Requirements"],"source_url":"https://iga.in.gov/ic/2026/Title_27.html#27-13-42-1","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-25T05:39:04Z","sha256":"8e15633836301df0b10b4aebf2e2f7c25008124d803e6df3188e359572ff19a4","source_id":"us-in","stale":false,"prev":"us-in/ic-27-13-41-2","next":"us-in/ic-27-13-43-1"},"notice":"GroundRules: Original legal text. Not legal advice."}